Author

Lukas Perkhofer

LONG TERM RESPONSE TO RITUXIMAB IN PATIENTS WITH TYPE 1 AUTOIMMUNE PANCREATITIS
LONG TERM RESPONSE TO RITUXIMAB IN PATIENTS WITH TYPE 1 AUTOIMMUNE PANCREATITIS

Lukas Perkhofer  et al.

PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER
PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER

Lukas Perkhofer  et al.

THE IMPACT OF ENDOSCOPIC ACTIVITY ON MUSCULOSKELETAL DISORDERS OF PRACTICING GASTROENTEROLOGISTS IN GERMANY
THE IMPACT OF ENDOSCOPIC ACTIVITY ON MUSCULOSKELETAL DISORDERS OF PRACTICING GASTROENTEROLOGISTS IN GERMANY

Lukas Perkhofer  et al.

A NOVEL SYNERGISTIC THERAPY APPROACH TO TREAT DNA DAMAGE REPAIR DEFICIENT PANCREATIC CANCER
A NOVEL SYNERGISTIC THERAPY APPROACH TO TREAT DNA DAMAGE REPAIR DEFICIENT PANCREATIC CANCER

Lukas Perkhofer  et al.

IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?
IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?

Lukas Perkhofer  et al.

RINT1 DOWNREGULATION DISRUPTS PANCREATIC DUCTAL ADENOCARCINOMA HOMEOSTASIS
RINT1 DOWNREGULATION DISRUPTS PANCREATIC DUCTAL ADENOCARCINOMA HOMEOSTASIS

Lukas Perkhofer  et al.

ATM DEFICIENCY DRIVES METABOLIC REPROGRAMMING IN PANCREATIC CANCER CELLS
ATM DEFICIENCY DRIVES METABOLIC REPROGRAMMING IN PANCREATIC CANCER CELLS

Lukas Perkhofer  et al.

FUNCTIONAL GENOMIC SCREENING DURING SOMATIC CELL REPROGRAMMING IDENTIFIES DKK3 AS A ROADBLOCK OF ORGAN REGENERATION
FUNCTIONAL GENOMIC SCREENING DURING SOMATIC CELL REPROGRAMMING IDENTIFIES DKK3 AS A ROADBLOCK OF ORGAN REGENERATION

Lukas Perkhofer  et al.

LOSS OF ATM DRIVES NUTRIENT STRESS-INDUCED METABOLIC REPROGRAMMING SUPPORTING PANCREATIC CANCER AGGRESSIVENESS
LOSS OF ATM DRIVES NUTRIENT STRESS-INDUCED METABOLIC REPROGRAMMING SUPPORTING PANCREATIC CANCER AGGRESSIVENESS

Lukas Perkhofer  et al.

DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER
DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER

Lukas Perkhofer  et al.

THE EPIGENETIC FACTOR EZH2 ORCHESTRATES ONCOGENIC FEATURES IN ATM-DEFICIENT PANCREATIC CANCER
THE EPIGENETIC FACTOR EZH2 ORCHESTRATES ONCOGENIC FEATURES IN ATM-DEFICIENT PANCREATIC CANCER

Lukas Perkhofer  et al.

EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK
EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK

Lukas Perkhofer  et al.

EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?
EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?

Lukas Perkhofer  et al.

REAL-LIFE EXPERIENCE OF PHARMACOTYPING AND RESPONSE PREDICTION USING PANCREATIC CANCER PATIENT-DERIVED ORGANOIDS
REAL-LIFE EXPERIENCE OF PHARMACOTYPING AND RESPONSE PREDICTION USING PANCREATIC CANCER PATIENT-DERIVED ORGANOIDS

Lukas Perkhofer  et al.

MODELLING PLASTICITY AND DYSPLASIA OF PANCREATIC DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
MODELLING PLASTICITY AND DYSPLASIA OF PANCREATIC DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Lukas Perkhofer  et al.

PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS AS A PERSONALIZED PRECLINICAL TOOL FOR DRUG RESPONSE PREDICTION
PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS AS A PERSONALIZED PRECLINICAL TOOL FOR DRUG RESPONSE PREDICTION

Lukas Perkhofer  et al.

MCCUNE-ALBRIGHT SYNDROME AND IPMN FORMATION MODELLED IN GNAS-MUTATED DUCT-LIKE ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
MCCUNE-ALBRIGHT SYNDROME AND IPMN FORMATION MODELLED IN GNAS-MUTATED DUCT-LIKE ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Lukas Perkhofer  et al.

PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER
PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER

Lukas Perkhofer  et al.

SERUM IGG4 LEVELS OUTPERFORM IGG4/IGG RNA RATIO IN DIFFERENTIAL DIAGNOSIS OF IGG4-RELATED DISEASE
SERUM IGG4 LEVELS OUTPERFORM IGG4/IGG RNA RATIO IN DIFFERENTIAL DIAGNOSIS OF IGG4-RELATED DISEASE

Lukas Perkhofer  et al.

A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE
A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE

Lukas Perkhofer  et al.

Item 1 - 20 / 28
1
2